DOSSIER · 13F-HR · Q2 2026
Decheng Capital LLC
$732M in tracked AUM across 14 positions as of Q2 2026.
DC
CIK 0002010850 · last filed Jun 30, 2026
AI Analysis · Q2 2026
Portfolio Overview
Decheng Capital LLC’s 13F filing for the period ending September 30, 2025, reveals a concentrated portfolio focused on the biotechnology and healthcare sectors. The firm manages a total portfolio value of approximately $255.92 million across 16 holdings. This represents a significant reduction in capital deployment, with the total portfolio value decreasing by 35.4% from the previous quarter's $395.97 million.
The portfolio is characterized by high conviction, with the t...
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology
Quarter at a glance — Q2 2026
Position-change comparison pending.
No quarter-over-quarter changes available.
Top 10 holdings
By portfolio weight as of Q2 2026.